Molecular Identification Of Hereditary Persistence Of Fetal Hemoglobin Type 2 (hpfh Type 2) In Patients From Brazil

dc.creatorGoncalves M.S.
dc.creatorFahel S.
dc.creatorFigueiredo M.S.
dc.creatorKimura E.J.
dc.creatorNechtman F.
dc.creatorStoming T.A.
dc.creatorArruda V.R.
dc.creatorSaad S.T.O.
dc.creatorCosta F.F.
dc.date1995
dc.date2015-06-26T17:14:35Z
dc.date2015-11-26T14:20:28Z
dc.date2015-06-26T17:14:35Z
dc.date2015-11-26T14:20:28Z
dc.date.accessioned2018-03-28T21:22:09Z
dc.date.available2018-03-28T21:22:09Z
dc.identifier
dc.identifierAnnals Of Hematology. , v. 70, n. 3, p. 159 - 161, 1995.
dc.identifier9395555
dc.identifier10.1007/s002770050050
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-0028959736&partnerID=40&md5=f192cde00c0095b6b6fcdaa3b23df0c0
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/95943
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/95943
dc.identifier2-s2.0-0028959736
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1244258
dc.descriptionThe HPFH deletion type 2 was first described in a patient from Ghana and is characterized by a large deletion of approximately 105 kb extension. We report here the results obtained in studying a black Brazilian patient who presented an association of β-thalassemia and HPFH type 2, using a PCR strategy for detection of the breakpoint region. This procedure allows a rapid molecular identification of this condition and is a reliable procedure for screening patients with a hematological picture of HPFH deletion types.
dc.description70
dc.description3
dc.description159
dc.description161
dc.languageen
dc.publisher
dc.relationAnnals of Hematology
dc.rightsfechado
dc.sourceScopus
dc.titleMolecular Identification Of Hereditary Persistence Of Fetal Hemoglobin Type 2 (hpfh Type 2) In Patients From Brazil
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución